Undetected rare neurodegenerative disorder identified by Singapore researchers

A joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) revealed that patients w...

November 6, 2020 | Friday | News
PPD targets multipurpose clinical research lab in China

PPD, Inc., a leading global contract research organization headquartered in the US, is opening a new laboratory in Suzho...

October 15, 2020 | Thursday | News
TaiGen filed US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, Limited ("TaiGen") announced on 5 Oct 2020 that it has filed an Investigational New Drug (...

October 5, 2020 | Monday | News
India can re-shape hybrid clinical trials

The Asia-Pacific region is fast emerging as one of the significant regions for clinical trials, with a study by Glo...

October 1, 2020 | Thursday | Opinion
COVID-19 vaccine administered by nasal spray receives Phase I study approval in China

Pharma companies around the world are exploring innovative approaches to develop therapeutics and vaccines against COVID...

September 30, 2020 | Wednesday | News
Study reveals postoperative pain can be reduced by using NOL monitoring

A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan...

September 30, 2020 | Wednesday | News
Samsung Biologics to develop treatment for retinal diseases with Kanaph Therapeutics

Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc...

September 24, 2020 | Thursday | News
World's first clinical trial with Sirolimus Coated Balloon for the treatment of SFA begins

Singapore's Concept Medical Inc., focused on vascular intervention drug delivery devices, on 15 Sep 2020 has a...

September 15, 2020 | Tuesday | News
Taiwan reports first COVID-19 patient recovery with eIND Silmitasertib treatment

Taiwan's Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Re...

September 14, 2020 | Monday | News
Empagliflozin to reduce the combined relative risk of cardiovascular complications

Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with ...

September 3, 2020 | Thursday | Analysis
Duke-NUS joins TriNetX to increase clinical trial adoption

Duke-NUS, the only graduate-entry medical school in Singapore, has joined the US based TriNetX global research netw...

September 2, 2020 | Wednesday | News
BeiGene signs licensing agreement with Singlomics for COVID-19 Abs

The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...

September 2, 2020 | Wednesday | News
CStone receives US FDA IND clearance to evaluate Sugemalimab Monotherapy

CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...

August 31, 2020 | Monday | News
Europital opening UK site for further expansion

Belgium based Europital, the global provider of medical management services for clinical research and drug dev...

August 27, 2020 | Thursday | News
Novotech receives "2020 Frost & Sullivan Asia-Pacific CRO Company of the Year’

Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the ‘2020 Frost & Su...

August 26, 2020 | Wednesday | News
Enrolment initiated in World's First RCT to treat BTK

Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first p...

August 27, 2020 | Thursday | News
Australia studies antimicrobial technology to eradicate SARS-CoV-2 on surfaces

  The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal, announced that...

August 27, 2020 | Thursday | News
Byondis Initiates Ph I trials of ADC as treatment of HER2-Expressing Solid Tumors

A Two-part Phase I Study With the Antibody-drug Conjugate SYD985 in Combination With Niraparib to Evaluate Safety, Pharm...

August 25, 2020 | Tuesday | News